2015 - Fellow of the Australian Academy of Health and Medical Science
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel;Stephen MacMahon;John Chalmers.
The New England Journal of Medicine (2008)
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Stephen S. Lim;Theo Vos;Abraham D. Flaxman;Goodarz Danaei.
The Lancet (2012)
1999 WORLD HEALTH ORGANIZATION-INTERNATIONAL SOCIETY OF HYPERTENSION GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION
M. Alderman;K. Arakawa;L. Beilin;J. Chalmers.
Journal of Hypertension (1999)
Canagliflozin and cardiovascular and renal events in type 2 diabetes
Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw.
The New England Journal of Medicine (2017)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
Mohammad H Forouzanfar;Lily Alexander;H Ross Anderson;Victoria F Bachman.
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
S. MacMahon;B. Neal;C. Tzourio;A. Rodgers.
The Lancet (2001)
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017
Jeffrey D. Stanaway;Ashkan Afshin;Emmanuela Gakidou;Stephen S. Lim.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint.
The New England Journal of Medicine (2019)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson.
The Lancet (2011)
Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015
Gregory A. Roth;Catherine Johnson;Amanuel Abajobir;Foad Abd-Allah.
Journal of the American College of Cardiology (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: